Compare Quanta Services Inc (PWR) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quanta Services Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Quanta Services Inc trades at $628.79 (market cap $94.26B), while State Street SPDR S&P Biotech ETF trades at $159.85. The key difference: Quanta Services Inc pays a 0.07% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Quanta Services Inc nearer its low. Which is the better fit depends on your goals.
| PWR | XBI | |
|---|---|---|
Market Cap | $94.26B | — |
Sector | Industrials | Broad Market / Factor |
52-Week High | $785.24 | $169.55 |
52-Week Low | $376.01 | $93.43 |
Enterprise Value | $100.36B | — |
Dividend Yield | 0.07% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PWR trades at $639.05, up 2.34% on the day, with a bullish technical signal and strong analyst support. The stock shows robust fundamentals, including a record $53 billion backlog and consecutive earnings beats, with Q2 2026 EPS of $4.24 surpassing estimates by 28%. Revenue growth accelerated to 41.1% year-over-year in Q2 2026, driven by infrastructure and data center demand.
The outlook remains positive given raised 2026 guidance and strategic positioning in AI-driven power projects, though high valuation multiples and investing cash outflows pose risks. Analyst consensus price target of $801.13 implies 25% upside, supported by 72% buy ratings. Execution on the massive backlog is critical for sustaining momentum.
XBI trades at $161.97, down 1.12% today, with technical indicators showing mixed signals amid a bearish overall trend. The ETF holds over 150 biotech companies and has rallied 76% in the past year, driven by M&A activity and positive clinical trial catalysts. Analyst coverage remains limited with a single hold rating, while recent news highlights sector optimism around cancer vaccine breakthroughs and improved capital access.
Outlook remains cautiously optimistic with potential for 8-14% returns over 6-12 months, though high volatility and regulatory risks persist. Key opportunities include ongoing pharmaceutical M&A and innovation in immunotherapy, while risks center on sector-specific volatility and policy uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Quanta Services Inc
Quanta Services is a leading provider of specialty contracting services, delivering comprehensive infrastructure solutions for the electric and gas utility, communications, pipeline, and energy industries in the United States, Canada, and Australia. Quanta reports its results under two reportable segments: electric power infrastructure solutions and underground utility and infrastructure solutions. In October 2021, the company completed the acquisition of Blattner, a provider of comprehensive engineering, procurement, and construction solutions to customers in the renewable energy industry.
Read more on PWR →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
